Skip to content
Screener

Danaher DHR Life Sciences — Goodwill, Foreign Currency Translation, Gain (Loss)

Other segment segments

Diagnostics
$56.75M+246%

Similar metrics at other companies

Bio-Rad Laboratories logo
BIOLife Science — Goodwill, Foreign Currency Translation, Gain (Loss)
-$2.7M
Donaldson Company logo
DCILife Sciences Segment — Goodwill, Foreign Currency Translation, Gain (Loss)
$3.9M+172%
IDEX logo
IEXHealth & Science Technologies — Goodwill, Foreign Currency Translation, Gain (Loss)
$6.2M+111%
Daktronics logo
DAKTLive Events — Goodwill, Foreign Currency Translation, Gain (Loss)
$0
TTC
TTCProfessional — Goodwill, Foreign Currency Translation, Gain (Loss)
$3.6M+820%
TTC
TTCResidential — Goodwill, Foreign Currency Translation, Gain (Loss)
$0-100%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$140.36B+0.4%
Enterprise value$163.87B+5.5%
P/E35.1×-5.9×
P/S5.6×-0.2×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The source filing: Danaher’s 10-K, filed February 24, 2026.

Filed
Feb 24, 2026, 4:36 PM EST
Fiscal year
FY2025
Accession
0000313616-26-000062
Line itemBiotechnologyLife SciencesDiagnosticsTotal
Balance, January 1, 2024$22,477$12,221$6,910$41,608
Attributable to 2024 acquisitions305305
Adjustments due to finalization of purchase price adjustments(23)(23)
Foreign currency translation and other(1,040)(198)(155)(1,393)
Balance, December 31, 202421,43712,3056,75540,497
Adjustments due to finalization of purchase price allocations99
Foreign currency translation and other1,8765422272,645
Balance, December 31, 2025$23,313$12,856$6,982$43,151

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Danaher's life sciences — goodwill, foreign currency translation, gain (loss)?
Danaher (DHR) reported life sciences — goodwill, foreign currency translation, gain (loss) of $135.5M in Q4 2025.
How has Danaher's life sciences — goodwill, foreign currency translation, gain (loss) changed year-over-year?
Danaher's life sciences — goodwill, foreign currency translation, gain (loss) increased by 373.7% year-over-year, from -$49.5M to $135.5M.
What is the long-term trend for Danaher's life sciences — goodwill, foreign currency translation, gain (loss)?
Over 3 years (2021 to 2025), Danaher's life sciences — goodwill, foreign currency translation, gain (loss) has grown at a -24.1% compound annual growth rate (CAGR), from -$1.24B to $542M.
What does life sciences — goodwill, foreign currency translation, gain (loss) mean?
This metric captures the impact of fluctuations in foreign exchange rates on the carrying value of goodwill denominated in currencies other than the reporting currency. It represents a non-cash adjustment that reflects the changing value of international assets due to currency volatility rather than operational performance. Investors monitor this to isolate the effects of global macroeconomic trends from the underlying health of the business segment.

Ask your AI about Danaher's life sciences — goodwill, foreign currency translation, gain (loss).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude